<DOC>
	<DOCNO>NCT00988494</DOCNO>
	<brief_summary>Safety efficacy DE-105 ophthalmic solution patient persistent corneal epithelial defect evaluate . Dose-dependent efficacy evaluate well .</brief_summary>
	<brief_title>Study DE-105 Ophthalmic Solution Patients With Persistent Corneal Epithelial Defect</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Has corneal epithelial defect decrease corneal sensitivity . Has undergone continuous treatment corneal epithelial defect 1 week longer . Presence disease active ocular infection , abnormal lid closure . History presence chemical burn , Stevens Johnson Syndrome , etc . History corneal transplantation , LASIK , hematopoietic stem cell transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>